Osaro Erhabor

Usmanu Danfodiyo University Teaching Hospital, Sokoto

Professor Erhabor Osaro is a Chartered Scientist and Fellow of the Institute of Biomedical Science (FIBMS), British Blood Transfusion Society (BBTS), Medical Laboratory Science Council (FMLSCN), and West African Postgraduate College of Medical Laboratory Science (FWAPCMLS). He holds a Ph.D. in Immunohematology from the Rivers State University of Science and Technology, Nigeria. He completed specialist training in Blood Transfusion and Laboratory Total Quality Management at the University of Greenwich, UK. He holds a Specialist Certificate in Transfusion Science Practice (SCTSP) from the British Blood Transfusion Society (BBTS). He is an alumnus of Francis Tuttle College of Technology, Oklahoma, USA. His teaching experience spans both the African continent and the United Kingdom. Dr. Osaro is the chairman of the Blood Transfusion Faculty of the West African Postgraduate College of Medical Laboratory Science. He is a council member and chairman of the Equality and Diversity Working Group of the BBTS. He is a recipient of several academic and professional awards including the Margaret Kenwright Scientist award. He is a registration and specialist portfolio verifier/examiner for the Institute of Biomedical Science of London. He has authored several scientific books and chapters and more than 160 articles on infectious diseases, occupational health, immunohematology, and transfusion medicine. Dr. Osaro is also an editorial board member and reviewer for several international scientific journals.

Osaro Erhabor

3books edited

6chapters authored

Latest work with IntechOpen by Osaro Erhabor

This book presents a comprehensive overview of sickle cell anemia, with chapters addressing diagnosis and clinical, psychosocial, and pharmacological management of patients with this disease. It is a vital resource for biomedical science and medical students, interns, pediatricians, general physicians, and other healthcare professionals involved in offering care and support to patients with sickle cell disease.

Go to the book